Strategikon Launches Two New Business Operation Services
Strategikon Pharma has announced that it is expanding the service offerings for their Clinical Maestro business operations platform with two offerings. Strategikon provides a SaaS product license for Clinical Maestro clinical trial RFP planning and budgeting, which includes implementation and training. Due to the effects of the pandemic, clinical trial pipelines have been disrupted by delays and changes to trial designs, increasing the use of remote technologies and tasks.
These two new services offer a Full-Service model and an Operator model. The new Operator model consists of assigning trained experts to assist, or directly operate the Sponsor’s instance of Clinical Maestro to expedite the output delivery. This Operator model is geared towards Biopharmaceutical sponsors who operate at high speed and may not have the trained staff available or the time to run clinical plans, budgets or RFP in Clinical Maestro.
A more robust model is the Clinical Maestro Full Service offering in which the Services team performs the analysis on Strategikon’s internal system and provides the Sponsor with a baseline budget and alternative scenarios, depending on the Sponsor’s requirement.
For more information, read the full release, here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
